Pranita D. Tamma, MD, MHS
Pranita D. Tamma, MD, MHS
Johns Hopkins University School of Medicine
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Combination therapy for treatment of infections with gram-negative bacteria
PD Tamma, SE Cosgrove, LL Maragakis
Clinical microbiology reviews 25 (3), 450-470, 2012
6222012
Safety of influenza vaccination during pregnancy
PD Tamma, KA Ault, C del Rio, MC Steinhoff, NA Halsey, SB Omer
American journal of obstetrics and gynecology 201 (6), 547-552, 2009
3422009
Association of adverse events with antibiotic use in hospitalized patients
PD Tamma, E Avdic, DX Li, K Dzintars, SE Cosgrove
JAMA internal medicine 177 (9), 1308-1315, 2017
2792017
Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia
PD Tamma, JH Han, C Rock, AD Harris, E Lautenbach, AJ Hsu, E Avdic, ...
Clinical Infectious Diseases 60 (9), 1319-1325, 2015
2522015
Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia
PD Tamma, KE Goodman, AD Harris, T Tekle, A Roberts, A Taiwo, ...
Clinical Infectious Diseases 64 (3), 257-264, 2017
2062017
Antimicrobial stewardship
PD Tamma, SE Cosgrove
Infectious Disease Clinics 25 (1), 245-260, 2011
1922011
Multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2
K Chiotos, M Hayes, DW Kimberlin, SB Jones, SH James, SG Pinninti, ...
Journal of the Pediatric Infectious Diseases Society 9 (6), 701-715, 2020
1642020
Treatment of multidrug-resistant Gram-negative infections in children
AJ Hsu, PD Tamma
Clinical infectious diseases 58 (10), 1439-1448, 2014
1432014
The use of cefepime for treating AmpC β-lactamase–producing Enterobacteriaceae
PD Tamma, SCT Girdwood, R Gopaul, T Tekle, AA Roberts, AD Harris, ...
Clinical infectious diseases 57 (6), 781-788, 2013
1382013
What is the more effective antibiotic stewardship intervention: preprescription authorization or postprescription review with feedback?
PD Tamma, E Avdic, JF Keenan, Y Zhao, G Anand, J Cooper, R Dezube, ...
Clinical Infectious Diseases 64 (5), 537-543, 2017
1292017
The use of noncarbapenem β-lactams for the treatment of extended-spectrum β-lactamase infections
PD Tamma, J Rodriguez-Baňo
Clinical Infectious Diseases 64 (7), 972-980, 2017
1212017
A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum β-lactamase–producing organism
KE Goodman, J Lessler, SE Cosgrove, AD Harris, E Lautenbach, JH Han, ...
Clinical Infectious Diseases 63 (7), 896-903, 2016
1202016
Phenotypic detection of carbapenemase-producing organisms from clinical isolates
PD Tamma, PJ Simner
Journal of clinical microbiology 56 (11), e01140-18, 2018
1172018
Chlorhexidine use in the neonatal intensive care unit: results from a national survey
PD Tamma, SW Aucott, AM Milstone
Infection Control & Hospital Epidemiology 31 (8), 846-849, 2010
1132010
Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials
PD Tamma, N Putcha, YD Suh, KJ Van Arendonk, ML Rinke
BMC infectious diseases 11 (1), 1-13, 2011
1062011
Comparison of 11 phenotypic assays for accurate detection of carbapenemase-producing Enterobacteriaceae
PD Tamma, BNA Opene, A Gluck, KK Chambers, KC Carroll, PJ Simner
Journal of clinical microbiology 55 (4), 1046-1055, 2017
1042017
Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score–matched …
D Chotiprasitsakul, JH Han, SE Cosgrove, AD Harris, E Lautenbach, ...
Clinical infectious diseases 66 (2), 172-177, 2018
922018
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)
KE Goodman, PJ Simner, PD Tamma, AM Milstone
Expert review of anti-infective therapy 14 (1), 95-108, 2016
822016
Sustained savings from a longitudinal cost analysis of an internet-based preapproval antimicrobial stewardship program
AC Sick, CU Lehmann, PD Tamma, CKK Lee, AL Agwu
Infection Control & Hospital Epidemiology 34 (6), 573-580, 2013
722013
Clostridium difficile Infection in Children: Current State and Unanswered Questions
PD Tamma, TJ Sandora
Journal of the Pediatric Infectious Diseases Society 1 (3), 230-243, 2012
682012
The system can't perform the operation now. Try again later.
Articles 1–20